
EGFR
Les inhibiteurs du récepteur du facteur de croissance épidermique (EGFR) sont des composés qui bloquent la signalisation de l'EGFR, un récepteur souvent surexprimé dans divers cancers et qui joue un rôle crucial dans l'angiogenèse. Les inhibiteurs de l'EGFR sont utilisés pour prévenir la croissance tumorale et les métastases en perturbant les voies qui favorisent la formation de vaisseaux sanguins dans les tumeurs. Ces inhibiteurs sont largement utilisés dans la recherche et le traitement du cancer. Chez CymitQuimica, nous offrons une sélection diversifiée d'inhibiteurs de l'EGFR de haute qualité pour soutenir vos recherches en oncologie et angiogenèse.
Produits appartenant à la catégorie "EGFR"
Trier par
Tyrphostin AG 879
CAS :Tyrphostin AG 879 (AG 879) effectively inhibits HER2/ErbB2 (IC50: 1 μM), 100- and 500-fold higher selective to ErbB2 than EGFR and PDGFR.Formule :C18H24N2OSDegré de pureté :99.05%Couleur et forme :SolidMasse moléculaire :316.46Desmethyl Erlotinib hydrochloride
CAS :Desmethyl Erlotinib hydrochloride (OSI 420) is an active metabolite of erlotinib which is an orally active EGFR tyrosin kinase inhibitor.Formule :C21H21N3O4·HClDegré de pureté :99.49%Couleur et forme :SolidMasse moléculaire :415.87Ref: TM-T6619
1mg59,00€2mg84,00€5mg115,00€10mg188,00€25mg335,00€50mg505,00€100mg720,00€1mL*10mM (DMSO)127,00€PROTAC EGFR degrader 8
CAS :PROTAC EGFR degrader 8 (T-184) is a PROTAC that selectively degrades the epidermal growth factor receptor (EGFR) with a DC50 of 15.56 nM in HCC827 cells.Formule :C40H46ClN11O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :796.32lavendustin A
CAS :lavendustin A (RG-14355) is a potent, cell-permeable inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.Formule :C21H19NO6Degré de pureté :98%Couleur et forme :Off-White SolidMasse moléculaire :381.38EGFR ligand-11
CAS :EGF Rligand-11, a target protein ligand for EGFR, is utilized in the synthesis of PROTAC MS154.Formule :C25H29ClFN5O4Couleur et forme :SolidMasse moléculaire :517.98RG14620
CAS :RG14620 (Tyrphostin RG14620) is an epidermal growth factor receptor (EGFR) inhibitor.Formule :C14H8Cl2N2Degré de pureté :99.56% - 99.82%Couleur et forme :SolidMasse moléculaire :275.13Ref: TM-T3554
2mg35,00€5mg52,00€10mg77,00€25mg137,00€50mg259,00€100mg432,00€500mg938,00€1mL*10mM (DMSO)58,00€BLU-945
CAS :BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs).Cost-effective and quality-assured.Formule :C28H37FN6O3SDegré de pureté :99.11% - 99.16%Couleur et forme :SolidMasse moléculaire :556.71,5-Dihydroxyxanthone
CAS :1,5-Dihydroxyxanthone inhibits EGFR-tyrosine kinase (IC50: 90.34 nM) and may block AChE/BChE.Formule :C13H8O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :228.203DA-0157
CAS :DA-0157 is an orally active inhibitor targeting EGFR and ALK, designed to overcome resistance mutations in non-small cell lung cancer (NSCLC). It effectively inhibits the proliferation of Ba/F3-EGFR Del19/T790M/C797S (IC50= 6.9 nM), Ba/F3-EGFR WT (IC50= 0.83 μM), Ba/F3-EML4-ALK-L1196M (IC50= 5.5 nM), and Ba/F3-EML4-ALK (IC50= 7.4 nM). Additionally, DA-0157 inhibits CYP2D6 with an IC50 of 5.26 μM and demonstrates antitumor activity in mouse models.Formule :C31H43BrN7O2PCouleur et forme :SolidMasse moléculaire :656.597TYRPHOSTIN B48
CAS :Formule :C16H12N2O3Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :280.2781EGFR-IN-127
EGFR-IN-127 is an ATP-competitive inhibitor targeting EGFR, with IC50 values of 136.3 nM for EGFRdel19 and 161.2 nM for EGFRdel19/T790M/C797S. This compound holds potential for the study of non-small cell lung cancer (NSCLC).Couleur et forme :Odour SolidEGFR/HER2/DHFR-IN-3
EGFR/HER2/DHFR-IN-3 (compound 4c) serves as an efficacious dual inhibitor specifically targeting EGFR/HER2, exhibiting IC50 values of 0.138 μM for EGFR and 0.Degré de pureté :98%Couleur et forme :Odour SolidIBI-334
IBI-334 is a bispecific antibody targeting both B7-H3 and EGFR. It features an EGFR arm responsible for signal blocking, connected to a modified B7-H3 arm that ensures optimal affinity and binding. The antibody is afucosylated to enhance its antibody-dependent cellular cytotoxicity (ADCC) effects. IBI-334 is widely applicable in EGFR-driven solid tumors.Couleur et forme :Odour LiquidBI-4020
CAS :BI-4020 is a fourth-generation, orally active, and non-covalent inhibitor of EGFR tyrosine kinase.Formule :C30H38N8O2Degré de pureté :100.00% - 98.44%Couleur et forme :SolidMasse moléculaire :542.68Ref: TM-T10534
1mg170,00€5mg398,00€10mg568,00€25mg848,00€50mg1.130,00€100mg1.510,00€200mg2.062,00€1mL*10mM (DMSO)472,00€CGP77675
CAS :CGP77675 (ZINC1488120) is a potent and selective inhibitor of Src family kinase with IC50s of 5-20 and 40 nM for the phosphorylation of peptide substrates andFormule :C26H29N5O2Degré de pureté :98.23%Couleur et forme :SolidMasse moléculaire :443.54Dalmitamig
Dalmitamig is a humanized IgG4κ antibody targeting EGFR/CD28, with HumanIgG4(S228P) kappa as its corresponding isotype control.Couleur et forme :Odour LiquidPD-149163 hydrochloride
PD-149163 hydrochloride is a neurokinin B agonist with antipsychotic activity, used for research on neurological diseases.Formule :C42H72ClN9O6Couleur et forme :SolidMasse moléculaire :834.53Rilematovir
CAS :Rilematovir (JNJ-678) inhibits fusion protein, has antiviral properties, low toxicity, and targets RSV treatment.Formule :C21H20ClF3N4O3SDegré de pureté :99.82%Couleur et forme :SolidMasse moléculaire :500.92Mutated EGFR-IN-1
CAS :Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activatingFormule :C25H31N7ODegré de pureté :98.91%Couleur et forme :SolidMasse moléculaire :445.56Allitinib tosylate
CAS :Allitinib tosylate (AST-1306) is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.Formule :C31H26ClFN4O5SDegré de pureté :98.46% - 98.68%Couleur et forme :SolidMasse moléculaire :621.08Losatuxizumab
CAS :Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody with potential anti-tumor activity for the study of advanced malignant solid tumors.Degré de pureté :95% - 95%Couleur et forme :LiquidNaquotinib
CAS :Naquotinib (ASP8273) (ASP8273) is an orally available, mutant-selective and irreversible EGFR inhibitor; (IC50s: 8-33 nM and 230 nM toward EGFR mutants and EGFRFormule :C30H42N8O3Degré de pureté :97.49%Couleur et forme :SolidMasse moléculaire :562.71Nimotuzumab
CAS :Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).Degré de pureté :95.00%Couleur et forme :LiquidWZ8040
CAS :WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I).Formule :C24H25ClN6OSDegré de pureté :97.42%Couleur et forme :SolidMasse moléculaire :481.01H-9 dihydrochloride
CAS :H-9 dihydrochloride: Strong PKA inhibitor, curbs 5-HT response and EGF signaling, affects pharyngeal function.Formule :C11H15Cl2N3O2SDegré de pureté :96.57%Couleur et forme :SolidMasse moléculaire :324.23CL-387785
CAS :Formule :C18H13BrN4ODegré de pureté :>98.0%(GC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :381.23Erlotinib
CAS :Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.Formule :C22H23N3O4Degré de pureté :98.19% - 99.98%Couleur et forme :White To Off-White PowderMasse moléculaire :393.44Butein
CAS :Butein is a cAMP-specific PDE inhibitor, protein tyrosine kinase inhibitor, and SIRT1 activator.Cost-effective and quality-assured.Formule :C15H12O5Degré de pureté :100% - 99.85%Couleur et forme :SolidMasse moléculaire :272.25Ref: TM-T6427
1mg43,00€2mg56,00€5mg88,00€10mg106,00€25mg213,00€50mg344,00€100mg550,00€1mL*10mM (DMSO)87,00€Genistein
CAS :Genistein (NPI 031L) is a natural soy isoflavone, a multi-targeted tyrosine kinase inhibitor. Genistein has antitumor effects. Cost effective and quality assured.Formule :C15H10O5Degré de pureté :98.22% - 99.69%Couleur et forme :Rectangular Or Six-Sided Rods From 60% Alcohol Dendritic Needles From Ether SolidMasse moléculaire :270.24YK-029A
CAS :YK-029A, an orally active EGFR mutant inhibitor, targets both EGFR T790M and EGFRex20ins mutations.Formule :C27H32N8O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :500.6Antiproliferative agent-34
CAS :Antiproliferative Agent-34 (Compound A14), a multitarget kinase inhibitor, demonstrates IC50 values of 177 nM for EGFR L858R/T790M and 1567 nM for EGFR WT.Formule :C27H27N7O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :529.55PD153035
CAS :PD153035 (NSC-669364) hydrochloride is an effective and selective inhibitor of EGFR (Ki/IC50: 5.2/29 pM, in cell-free assays); little inhibitory against FGFR,Formule :C16H14BrN3O2Degré de pureté :98.47% - 99.29%Couleur et forme :SolidMasse moléculaire :360.21Rostafuroxin
CAS :Rostafuroxin (PST 2238) has been used in trials studying the treatment of Essential Hypertension.Formule :C23H34O4Degré de pureté :100% - 99.08%Couleur et forme :SolidMasse moléculaire :374.51EGFR/HER2/DHFR-IN-2
EGFR/HER2/DHFR-IN-2 (Compound 4b) serves as an inhibitor for EGFR, HER2, and DHFR, with IC50 values of 0.248, 0.156, and 0.138 μM, respectively.Degré de pureté :98%Couleur et forme :Odour SolidCurcumin (Synthetic)
CAS :Formule :C21H20O6Degré de pureté :>97.0%(T)Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :368.39ES-072
CAS :ES-072, a selective inhibitor targeting the EGFR mutant (EGFR-T790M), is administered orally. By hindering EGFR-T790M activity, it activates GSK3α, which subsequently leads to the phosphorylation of PD-L1 at Ser279 and Ser283. This phosphorylation facilitates the recruitment of the E3 ubiquitin ligase ARIH1, resulting in the ubiquitination and proteasomal degradation of PD-L1. Such a process not only curtails the growth of cancer cells but also amplifies the anti-tumor immune response by diminishing PD-L1 levels. ES-072 has shown efficacy in impeding the proliferation of non-small cell lung cancer (NSCLC) cells.Formule :C25H27F3N8O2Couleur et forme :SolidMasse moléculaire :528.53Icotinib Hydrochloride
CAS :Icotinib Hydrochloride, an oral EGFR inhibitor (BPI-2009H), may halt cancer growth by blocking EGFR signaling.Formule :C22H22ClN3O4Degré de pureté :99.77%Couleur et forme :SolidMasse moléculaire :427.88TAS6417
CAS :Zipalertinib (TAS6417, CLN-081) is a novel, highly potent, orally active covalent EGFR tyrosine kinase inhibitor.Cost-effective and quality-assured.Formule :C23H20N6ODegré de pureté :99.71%Couleur et forme :SolidMasse moléculaire :396.44Ref: TM-T16996
1mg87,00€2mg124,00€5mg188,00€10mg311,00€25mg630,00€50mg1.008,00€100mg1.549,00€500mg3.117,00€1mL*10mM (DMSO)215,00€ALK/EGFR-IN-1
CAS :ALK/EGFR-IN-1 (Compound 8l) is a dual inhibitor targeting both ALK and EGFR, effectively blocking their phosphorylation.Formule :C27H34ClN7O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :572.12(2E)-N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide
CAS :Formule :C30H29ClN6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :557.0426600000001EGFR-IN-11
CAS :EGFR-IN-11 selectively blocks EGFR-tyrosine kinase and promotes apoptosis; targets EGFRL858R/T790M/C797S, IC50=18 nM; halts cell cycle at G0/G1.Formule :C29H35N9O2SDegré de pureté :99.37%Couleur et forme :SolidMasse moléculaire :573.71Ref: TM-T11158
1mg51,00€5mg116,00€10mg192,00€25mg304,00€50mg420,00€100mg560,00€1mL*10mM (DMSO)147,00€Lapatinib Ditosylate
CAS :Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).Formule :C29H26ClFN4O4S·2C7H8O3SDegré de pureté :99.41%Couleur et forme :Yellow SolidMasse moléculaire :925.46CP-380736
CAS :CP-380736 (PF-00520893) inhibits EGFR, a kinase key in cancer-signaling pathways like MAPK, JNK, and Akt.Formule :C14H18N2O5Degré de pureté :99.68%Couleur et forme :White To Off-White SolidMasse moléculaire :294.3Lifirafenib
CAS :Lifirafenib (Beigene-283) is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM for the recombinantFormule :C25H17F3N4O3Degré de pureté :98% - 98.25%Couleur et forme :SolidMasse moléculaire :478.42Ref: TM-T22272
1mg35,00€5mg69,00€10mg97,00€25mg190,00€50mgÀ demander100mgÀ demander1mL*10mM (DMSO)89,00€Pelitinib
CAS :Pelitinib (EKB-569) (EKB-569) is an effective irreversible EGFR inhibitor (IC50: 38.5 nM).Formule :C24H23ClFN5O2Degré de pureté :98.37% - 99.86%Couleur et forme :Off-White SolidMasse moléculaire :467.92Tyrphostin B44, (+) enantiomer
CAS :Tyrphostin B44, (+) enantiomer is an inhibitor of epidermal growth factor receptor (EGFR) kinase with IC50 of 0.86 μM and has less active than the (-)Formule :C18H16N2O3Degré de pureté :97.18%Couleur et forme :SolidMasse moléculaire :308.33Ref: TM-T22450
1mg51,00€2mg73,00€5mg105,00€10mg164,00€25mg275,00€50mg378,00€100mg543,00€200mg738,00€1mL*10mM (DMSO)117,00€Tarloxotinib bromide
CAS :Tarloxotinib bromide (TH-4000) is an irreversible inhibitor of EGFR/HER2.Formule :C24H24Br2ClN9O3Degré de pureté :97.15%Couleur et forme :SolidMasse moléculaire :681.77Ref: TM-T13088
1mg140,00€5mg283,00€10mg432,00€25mg707,00€50mg938,00€100mg1.311,00€1mL*10mM (DMSO)437,00€Os30
Os30 is a potent fourth-generation EGFR inhibitor, specifically targeting the EGFRC797S-TK mutation with IC50 values of 18 nM for EGFRDel19/T790M/C797S TK andDegré de pureté :98%Couleur et forme :Odour Solid(E)-AG 99
CAS :(E)-AG 99 ((E)-Tyrphostin AG 99) is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).Formule :C10H8N2O3Degré de pureté :99.23%Couleur et forme :SolidMasse moléculaire :204.18SST0116CL1
CAS :SST0116CL1 is an HSP90 inhibitor (IC50: 0.21 μM) that targets the ATP-binding pocket of Hsp90, disrupting its chaperone function and leading to the degradation of client proteins (EGFR, CDK4, and AKT). It induces the degradation of Her2 in BT-474 cells (IC50: 0.2 μM) and exhibits antiproliferative activity, inhibiting tumor growth.Formule :C22H31ClN4O6Couleur et forme :SolidMasse moléculaire :482.96